BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its COVID-19 vaccine, the company said in filings. The German company, which partners …
Germany’s BioNTech Settles With US Agency, UPenn Over COVID Vaccine Royalties
